Investor Presentaiton
9th largest generic company in France; among
top 20 generic companies in Spain
Among top 10 in Euro 3 bn French generics market with over 2.5% market share
■ Launched >200 presentations (>90 molecules) in France so far
Focusing on expanding market coverage thru new product launches incl. Day 1 opportunities
Recognized as one of the most reliable partner to deal with by the pharmacists - a result of
continuous focus on enrichment of customer relations
Among top 20 in Euro 0.8 bn Spanish market
■ Launched >35 molecules in Spain so far
■ Plan to increase product portfolio to tap less penetrated market
Overall, registered sales of Rs. 2,755 Mio. in FY 10-11 in Europe, up by 13% in Euro terms
116
Regulatory pipeline from India
67
21
64
49 46
KEY STRENGTHS
Leveraging India's low cost base - started
supplying over 35% of France sales from
India
New product filings include 39 products for
Spanish market
New Products
Site Transfers
Filed
Approved
Launched
11View entire presentation